Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies -- Kainova Therapeutics rebrand reflects expanding capabilities powering next stage of ...
Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, ...
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using Biohaven's proprietary MoDE and next-generation, highly selective ...
University of New Mexico researchers found that the immune enzyme OTULIN drives tau production, brain inflammation and aging.
When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life.
Northwestern University researchers have reported a novel injectable nanomaterial that crossed the blood–brain barrier and ...
The Brighterside of News on MSN
Experimental drug can sharply reduce amyloid beta's impact on Alzheimer’s
Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.
Responsive polymers and smart materials adapt to stimuli, providing solutions to drug delivery, tissue engineering, and even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback